We further found that NPC1 and NPC2 mRNA expression was upregulated after treatment of GBM cells with PD or U18886A, which could be as a result of compensatory response to the inhibition of NPCs (Fig. 4D). The gene discussed is NPC2; the disease is glioblastoma.